Post COVID-19 condition, unspecified

Clinical trials for Post COVID-19 condition, unspecified explained in plain language.

Never miss a new study

Get alerted when new Post COVID-19 condition, unspecified trials appear

Sign up with your email to follow new studies for Post COVID-19 condition, unspecified, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Paxlovid tested as a shield against long COVID in 2,000-Person trial

Prevention Ongoing

This phase 3 trial tests whether taking Paxlovid (nirmatrelvir/ritonavir) during acute COVID-19 can prevent long COVID. About 2,000 adults aged 18-64 with a recent positive test and symptoms will receive either Paxlovid or a placebo for 5 days. Researchers will track long COVID s…

Matched conditions: POST COVID-19 CONDITION, UNSPECIFIED

Phase 3 • Sponsor: Haukeland University Hospital • Aim: Prevention

Last updated Jun 27, 2026 07:58 UTC

Post COVID-19 condition, unspecified

Get alerted when new Post COVID-19 condition, unspecified trials appear

Paxlovid tested as a shield against long COVID in 2,000-Person trial